These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3665630)

  • 41. [Pharmacokinetic, bacteriological and clinical evaluation of biapenem (L-627) in the pediatric field].
    Iwai N; Nakamura H; Taneda Y
    Jpn J Antibiot; 1994 Dec; 47(12):1706-22. PubMed ID: 7877252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Fundamental and clinical studies on cefuzoname in the pediatric field].
    Toyonaga Y; Sugita M; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1987 Apr; 40(4):843-65. PubMed ID: 3613094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anemia during Haemophilus influenzae type b meningitis: lack of an effect of chloramphenicol.
    Sherry B; Smith AL; Kronmal RA
    Dev Pharmacol Ther; 1989; 12(4):188-99. PubMed ID: 2766922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacokinetic and clinical studies on cefodizime in the pediatric field. Pediatric Study Group of Cefodizime].
    Fujii R; Arimasu O; Meguro H; Hiruma F; Sugie N; Abe T; Nakazawa S; Sato H; Narita A; Matsumoto K
    Jpn J Antibiot; 1989 May; 42(5):1173-93. PubMed ID: 2664256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical and pharmacokinetic evaluation of ceftazidime in children].
    Fujita K; Sakata H; Murono K; Yoshioka H; Maruyama S; Sanae N; Takimoto M
    Jpn J Antibiot; 1984 Mar; 37(3):329-37. PubMed ID: 6376845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Laboratory and clinical studies on ceftazidime in the field of pediatrics].
    Kuno K; Yafuso M; Miyachi Y; Nakashima T; Ichihara K; Ueda S
    Jpn J Antibiot; 1984 Mar; 37(3):469-84. PubMed ID: 6376856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bacteriological, pharmacokinetic and clinical studies on cefteram pivoxil in the pediatric field].
    Toyonaga Y; Imai H; Sugita M; Fukushima Y; Yamazaki M; Hori M
    Jpn J Antibiot; 1989 Aug; 42(8):1799-814. PubMed ID: 2810743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
    Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
    Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical evaluation of cefteram pivoxil fine granules in pediatric infections].
    Wagatsuma Y; Takase A; Fukushima N; Ishikawa A; Takahashi S
    Jpn J Antibiot; 1989 Aug; 42(8):1735-44. PubMed ID: 2810737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experiences with ciclacillin in pediatric practice].
    Krauthammer W
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1435-6. PubMed ID: 809689
    [No Abstract]   [Full Text] [Related]  

  • 53. Chloramphenicol pharmacokinetics in African children with severe malaria.
    Kokwaro GO; Muchohi SN; Ogutu BR; Newton CR
    J Trop Pediatr; 2006 Aug; 52(4):239-43. PubMed ID: 16126805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Fundamental and clinical studies of aztreonam in the field of pediatric].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H; Nakazawa S; Chikaoka H; Kamigaki M; Koido R; Nakada Y
    Jpn J Antibiot; 1985 Nov; 38(11):3239-62. PubMed ID: 4094057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative bioavailability and pharmacokinetics of chloramphenicol after intravenous chloramphenicol succinate in premature infants and older patients.
    Nahata MC; Powell DA
    Dev Pharmacol Ther; 1983; 6(1):23-32. PubMed ID: 6839912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acidosis as a presenting feature of chloramphenicol toxicity.
    Evans LS; Kleiman MB
    J Pediatr; 1986 Mar; 108(3):475-7. PubMed ID: 3950830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic therapy for bacterial meningitis in children in developing countries.
    Kumar P; Verma IC
    Bull World Health Organ; 1993; 71(2):183-8. PubMed ID: 8490981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical study on imipenem/cilastatin sodium in the field of pediatrics].
    Minamitani M; Hachimori K; Kaneda K
    Jpn J Antibiot; 1986 Jul; 39(7):1817-27. PubMed ID: 3464780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Laboratory and clinical studies on cefprozil granules in pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1992 Nov; 45(11):1526-36. PubMed ID: 1494235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
    Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.